General information, not legal or regulatory advice. Confirm current agency, holder, import, and post-market rules with qualified advisers. We do not invent Pure Global, freelancer, or competitor rates. bioaccess® pricing is the two-part model published on market-access: a one-time registration fee, then an annual holder fee from year 2. No unpublished client. No PHI. Always bioaccess®.
If you searched Colombia RA consultant medical device, INVIMA regulatory consultant, or Colombia regulatory affairs consultant medical device, you were looking for registration / operator clarity often mislabeled as freelance advice. This page owns that search intent: registration operator vs freelance advice. It does not flip into “do FIH in Colombia.” No named freelancers. No PHI. Always bioaccess®.
The leak: a consultant who drafts INVIMA dossiers or advises on classification is still not the ethics calendar + IOR + site network + inspection-ready ops stack — and in Colombia, bioaccess® runs first-in-human studies now. INVIMA commercial medical-device registration and holder / IOR operations are also core. bioaccess® is the LATAM FIH CRO, including in Colombia, and the local RA / IOR operator for Colombia registration.
bioaccess® runs first-in-human studies in Colombia now, and Colombia’s regulatory framework is changing for the better. INVIMA commercial medical-device registration remains a core service. Always bioaccess®.
What the search usually means vs what execution requires
- Search intent often means: someone who “knows INVIMA” for registro sanitario, CCAA importer rules, or historical trial coaching.
- Registration execution requires: Colombian legal entity as titular on the sanitary registration; CCAA importer rules beside the holder; certified translations where required; tecnovigilancia as holder; government fees and RFI ownership — see INVIMA medical device registration checklist.
- A freelance INVIMA RA retainer usually covers: dossier outline and agency etiquette — not own-entity titular and not post-market as holder.
- FIH execution is a separate offer. bioaccess® runs first-in-human studies in Colombia now; this page covers registration.
INVIMA registration operator stack (not new FIH)
Use Colombia INVIMA Registration Holder / IOR and the checklist above. Colombia pricing: a one-time registration fee of $4,000 (Class I), $6,250 (Class IIa/IIb) or $9,000 (Class III), then an annual holder fee of $3,900 from year 2 (rate card). We will not invent INVIMA freelancer rates.
For context on why sponsors still find “CRO in Colombia” in search, see CRO in Colombia — read that page together with the public line above. Country 2 for new FIH can be Panama, Chile, Brazil, Mexico, El Salvador or Colombia, where bioaccess® runs first-in-human studies now.
Investigational import (for a protocol in Colombia or another country) is importer of record for clinical trial devices — a trial object, not this Colombia registration SKU.
Registration operator vs freelance advice
- Who is the titular? INVIMA names a Colombian legal entity. A consultant who helps you appoint is not the titular.
- Who owns CCAA importer rules? Importer rules sit next to the holder — see the live checklist — not instead of it.
- Who runs tecnovigilancia after the certificate is live? Holder duty. A one-time filing shop is not that.
- Who owns RFIs and government fees? Operator clarity beats a vague “we’ll help with INVIMA” email.
- Who refuses to sell you new FIH in Colombia? bioaccess® — on the public line — while still owning commercial registration.
How sponsors mis-buy “INVIMA RA”
The mis-buy on Colombia is specific: sponsors search INVIMA regulatory consultant when they need either (a) commercial titular / CCAA / tecnovigilancia operations, or (b) first-in-human trial execution. This page answers (a); for (b), bioaccess® runs first-in-human studies in Colombia now. Use INVIMA medical device registration checklist and INVIMA holder / IOR. For FIH country selection, Colombia, Panama, Chile, Brazil, Mexico and El Salvador are all options. Always bioaccess®.
Frequently asked questions
Is an INVIMA regulatory consultant a CRO?
No. This page sells clarity on registration operator vs freelance advice, with bioaccess® as the holder / IOR operator for commercial INVIMA work.
Does bioaccess® run first-in-human studies in Colombia?
Yes. bioaccess® runs first-in-human studies in Colombia now, and Colombia’s regulatory framework is changing for the better. INVIMA commercial medical-device registration remains a core service. Always bioaccess®.
Does bioaccess® replace freelancers?
We do not name freelancers. When the job is INVIMA registration holder / IOR, hire the operator on market-access — not only dossier coaching.
Can I use bioaccess® market access for an investigational device in Colombia?
No. The public card is for already FDA-cleared or CE-marked devices. For an investigational device, bioaccess® runs first-in-human studies in Colombia now; investigational import is covered on the trial IOR blog.
Siblings?
Dominican Republic RA Consultant; Regulatory Affairs Consultant Latin America; Mexico RA Consultant / COFEPRIS; Brazil RA Consultant / ANVISA
Next step
Colombia RA / INVIMA search → registration operator path (not new FIH): contact bioaccess® · market-access · INVIMA checklist · INVIMA holder / IOR · CRO in Colombia (with public FIH line) · siblings Dominican Republic RA Consultant; Regulatory Affairs Consultant Latin America; Mexico RA Consultant / COFEPRIS; Brazil RA Consultant / ANVISA.
Julio G. Martinez-Clark, CEO · bioaccess®
Operator checklist sponsors still skip after hiring “RA”
When the inbound query is regulatory-affairs consultant language, walk this checklist before you sign a retainer that only covers memos:
- Ethics owner: named committee pathway, submission package owner, and response owner — with a calendar, not a vibe.
- Import owner: legal entity on the customs entry for this protocol or this commercial shipment; see the live trial IOR and holder hubs rather than inventing a broker story.
- Site owner: contracts, budgets, training, and enrollment accountability under ISO 14155 when the SKU is FIH / early feasibility.
- Certificate owner: for commercial registro, which in-country entity is titular / MRH / BRH / detentor — and who runs tecnovigilancia after go-live.
- Inspection owner: TMF/ISF discipline, monitoring, and CAPA. A classification PDF does not answer an inspector.
- Country-select owner: pick the FIH country the device needs — Colombia, Mexico, Brazil, Panama, Chile or El Salvador — where the live hubs support it; bioaccess® runs first-in-human studies in Colombia now.
- Commercial holder: if the SKU is already-cleared devices, use bioaccess® market access (two-part pricing: a one-time registration fee per country by device class, then a lower annual holder fee from year 2 (published for Mexico, Colombia, Brazil, Peru and Argentina on the rate card)) and do not invent freelancer comparables on this page.
- Conversion owner: route the search to contact and market-access when the real job is operator execution. Always bioaccess®.
bioaccess® is a DBA of IMH ASSETS CORP. Julio G. Martinez-Clark, Co-Founder and CEO. The founder podcast is Global Trial Accelerators™. This page is public content only. It is not a hospital site page and not insurance underwriting. Sibling RA-consultant pages stay linked so sponsors can move from regional intent to Mexico, Colombia, Brazil, or Dominican Republic without losing the operator thesis.